ArticleThe journal of nursing research : JNR2025
Immunotherapy Decision-Making Experiences of Patients With Cancer and Their Family Caregivers: A Qualitative Study.
Article in The journal of nursing research : JNR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Knowledge and attitudes of family members of cancer patients towards immunotherapy toxicity and health management.Human vaccines & immunotherapeutics · 2026Article
- Identifying Distinct Quality-of-Life Profiles in Prostate Cancer Patients: A Latent Profile Approach.Current oncology (Toronto, Ont.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with cancer and their families anticipate that innovative treatment options such as immunotherapy may improve survival and quality of life. Qualitative interviews have rarely been used to examine the immunotherapy-related decision-making experiences of cancer patients and their family caregivers. PURPOSE: This study was developed to explore the factors and reasons influencing the decisions of patients with cancer and their family caregivers to accept immunotherapy.
methodsBetween October 2019 and January 2021, data were collected using in-depth interviews that were conducted face-to-face in a semistructured format and audio-recorded. Content analysis was performed, and the Consolidated Criteria for Reporting Qualitative Research checklist was applied.
resultsFifteen patients with cancer in Taiwan who had received immunotherapy and 17 family caregivers were enrolled as participants. Three main themes were common among the considerations of patients and caregivers with regard to their decision-making to undergo immunotherapy. These included (a) putting decisions in the hands of health professionals, (b) the value of life surpasses all other considerations, and (c) practical considerations such as treatment side effects, financial burden, and the effects of immunotherapy. CONCLUSIONS/IMPLICATIONS FOR PRACTICE: The immunotherapy decision-making experiences of patients with cancer and their family caregivers in Taiwan were explored in this study. The generally low level of medical expertise identified among the participants emphasizes the importance of fostering a shared approach to immunotherapy decision-making. Also, oncology nurses should prioritize the inherent worth of patients and the emotions of their family caregivers to bolster their confidence and sense of self-worth. Notably, experiencing severe side effects with previous treatments was found to be a strong predictor of immunotherapy choice, highlighting the critical importance of regular assessment of patients' immunotherapy experiences in clinical practice. Also, financial concerns were confirmed as an important factor affecting patient-centered care. Thus, when needed, additional financial support should be provided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.